Key result
Urgent endo-epicardial ablation via subxiphoid window resolves drug-resistant VT storm in an elderly hemodialysis patient.
Why the study?
Endo-epicardial ablation of scar-related VT reduces recurrence and mortality compared with endocardial-only ablation, but it carries a higher incidence of procedural complications.
Case Report (n=1)
Endo-epicardial catheter ablation with a surgically subxiphoid pericardial window can be successfully performed for drug-resistant VT storm in high-risk, extremely old hemodialysis patients.
May support feasibility in select extreme-risk VT storm cases; leaves open generalizability and safety in larger cohorts.
Ischemic cardiomyopathy is the most common cause of scar-related ventricular tachycardia (VT) leading to sudden cardiac death. Catheter ablation of VT is important in managing drug-refractory VT.1 There has been a recent rise in the performance of epicardial access and mapping ablation for treating VT because of epicardial or transmural location of the clinical VT isthmuses.2 While the endo-epicardial approach for ablation of scar-related VT is associated with lower rates of VT recurrence and subsequent mortality than endocardial-only VT ablation, it is associated with a greater incidence of procedural complications.
No takes yet. Share an insight, caveat, or question.
Kasai et al. (2023) conducted a case report in Drug-resistant ventricular tachycardia storm, ischemic cardiomyopathy (n=1). Urgent, single-stage endo-epicardial catheter ablation with a surgically subxiphoid pericardial window was evaluated. Urgent, single-stage endo-epicardial catheter ablation with a surgically subxiphoid pericardial window successfully treated a drug-resistant VT storm in an extremely old hemodialysis patient.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: